IIT Bombay's Molecular Scalpel: A New Reaction Turns Fatty Acids Into Anti-Cancer Rings

Some of the most useful molecules in medicine are rings — compact loops of carbon and oxygen that lock a drug into the exact shape a target protein will recognise. Building those rings from scratch is one of the quiet, expensive bottlenecks of drug discovery, because the raw materials chemists usually begin with — long, straight chains of carbon such as fatty acids — are frustratingly featureless. Every carbon in the middle of such a chain looks almost identical to its neighbours, and coaxing a reaction to grab one specific carbon deep inside the chain, and no other, has been a decades-old problem in synthetic chemistry.

A team at the Indian Institute of Technology Bombay has now reported a way to do exactly that, in a paper published in the journal Nature. Led by Professor Debabrata Maiti of the Department of Chemistry, with co-authors Tanay Pal, Md Saimuddin Sk, Yazhinimuthu C M and Animesh Ghosh, the group has designed a chemical system that reaches down a plain carbon chain, selects a single distant carbon atom, and stitches the chain shut into a ring.

The needle in a carbon haystack

To appreciate the achievement, it helps to picture the problem. Chemists have long been good at modifying the reactive ends of a molecule — the parts that already carry a chemical "handle." The hard territory is the long, inert middle of a hydrocarbon chain, where the carbon–hydrogen bonds are strong, plentiful and nearly indistinguishable. Selectively activating one such bond, far from any existing handle, is what specialists call distal C–H functionalisation, and it is one of the field's most sought-after capabilities precisely because nature packs so much chemical value into those hard-to-reach positions.

How the reaction works

The IIT Bombay reaction, which the authors describe as a distal desaturative lactonization, folds two difficult steps into one operation. First, a specially designed helper molecule — a ligand — steers a metal catalyst toward a carbon atom set far from the molecule's active end, overriding the usual preference for the nearest reactive site. Second, rather than simply swapping in a new atom, the method strips away hydrogen to forge a new double bond and closes the chain into a lactone: an oxygen-containing ring that recurs throughout natural products and pharmaceuticals. Performing that distant, or "distal," chemistry with this degree of control is what makes the result notable — it turns an ordinary stretch of chain into a functional ring on demand.

From soursop to the lab bench

To show the method was more than a laboratory curiosity, the team used it to make muricatacin, a natural compound found in the soursop plant (Annona muricata, known in parts of India as Laxman phal). Muricatacin has drawn scientific interest because laboratory studies have reported anti-cancer activity — but obtaining it the old way is punishing. Extracting the compound directly from the plant yields only about 15 milligrams from roughly 15 kilograms of plant material, and even then it comes mixed with other substances.

Using the new reaction, the researchers assembled muricatacin and a structural analogue in just three steps, starting from margaric acid — a cheap, readily available fatty acid — and then evaluated the products for anti-cancer activity. Compressing a difficult natural-product synthesis into three steps from a commodity feedstock is precisely the kind of shortcut that makes a laboratory method attractive to drug developers, and it is the clearest demonstration the paper offers that the chemistry works on molecules people actually care about.

Why it matters for Indian pharma

India is one of the world's largest producers of generic medicines, yet much of its pharmaceutical value chain still leans on imported intermediates and on synthetic routes designed elsewhere. Tools that build complex molecules faster, from simpler and cheaper starting materials, feed directly into that ecosystem — shortening syntheses, cutting the number of steps, and reducing the solvent and reagent waste that every additional step generates. The authors frame their work as a way to provide "rapid access to biologically relevant frameworks," including scaffolds relevant to traditional medicine.

The environmental angle matters too. Every step removed from a synthesis is waste avoided, and the reaction's ability to build rings without first installing reactive groups aligns with the broader push in chemistry toward greener, more atom-efficient methods. For a country trying to move up the pharmaceutical value chain — from manufacturing known drugs to designing new ones — homegrown reactions that appear in the pages of Nature are more than academic bragging rights; they are the kind of foundational capability that new molecules are built on.

The road ahead

A reaction demonstrated in a research paper is a proof of principle, not a factory process. Scaling selective catalysis, controlling catalyst costs, and confirming the biology of any resulting molecules are each separate journeys, and most laboratory breakthroughs never make it to a production plant unchanged. But the significance of the IIT Bombay result lies in the capability it unlocks rather than the single molecule it made. If chemists can reliably reach a chosen carbon far along an ordinary chain and close it into a ring, an entire class of ring-shaped drug candidates that were previously awkward or costly to reach becomes fair game — designed and demonstrated in an Indian academic lab, and published in one of science's most competitive venues.

Sources

• Nature — Ligand-enabled distal desaturative lactonization of aliphatic acids
• The Free Press Journal — IIT Bombay scientists report breakthrough in catalytic chemistry
• IIT Alumni UK — IIT Bombay discovery could make drug discovery faster, cheaper and more sustainable
• Biotecnika — IIT Bombay cracks a drug discovery puzzle